Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2023-06-13 Proxy Solicitation & In…
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
DFAN14A
Proxy Solicitation & Information Statement
2023-06-13 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or additional materials related to a company's annual meeting of stockholders. It contains a letter from the Board of Directors to shareholders discussing director nominations, company strategy, and urging votes on proxy cards. The document is not a financial report, earnings release, or audit report, but rather materials soliciting shareholder votes and providing information relevant to the annual meeting. The SEC form DEFA14A corresponds to Definitive Additional Proxy Materials, which fall under the category of Proxy Solicitation & Information Statement (PSI). The document length is substantial and contains detailed information aimed at shareholders for voting purposes, consistent with PSI filings.
2023-06-13 English
DEFA14A
Remuneration Information Classification · 95% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically labeled as a "DEFA14A" which stands for Definitive Additional Materials to a Proxy Statement. It contains detailed information from the Board of Directors addressing stockholders about the upcoming Annual Meeting, discussing director nominations, corporate governance issues, and shareholder voting recommendations. The content focuses on management and board-related matters, including director elections and corporate strategy, rather than financial results or audit information. The presence of the SEC form type Schedule 14A and the nature of the content clearly identify this as a Remuneration Information or Proxy Solicitation document. Given the detailed discussion of director nominees and voting, and the form type, the best fitting category is "DEF 14A" which covers executive and director compensation and proxy materials. The document length (15,000 characters) and detailed content confirm it is not a brief announcement or a simple regulatory filing. Therefore, the classification is DEF 14A with high confidence.
2023-06-12 English
DFAN14A
Proxy Solicitation & Information Statement
2023-06-12 English
Remuneration Information 2023
Remuneration Information Classification · 95% confidence The document is a letter from Masimo Corporation responding to a comment from the SEC staff regarding a DEFA14A filing dated June 6, 2023. The DEFA14A form is a definitive additional proxy solicitation material, which relates to remuneration and compensation disclosures. The letter discusses clarifications about the Change in Control provisions in proxy materials and mentions filing additional proxy materials. The document is not the proxy statement itself but a correspondence related to it. Given the focus on executive compensation and proxy materials, the most appropriate classification is Remuneration Information (DEF 14A). The document length is short and it is a letter responding to SEC comments on a DEF 14A filing, not a full report or announcement of a report publication, so it is not RPA or RNS. Therefore, the classification is DEF 14A with high confidence.
2023-06-09 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or related materials filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It discusses matters related to the company's 2023 Annual Meeting of Stockholders, including board changes and voting matters. It is not the Annual Report, nor an earnings release or other financial report. The document is specifically titled as a proxy statement and contains solicitation materials for shareholder voting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is over 6000 characters and contains substantive information, not just an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2023-06-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.